CRYO-CELL INTERNATIONAL, INC. Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability
CRYO-CELL INTERNATIONAL, INC. (CCEL) reported Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability of $2.79 thousand for the 12-month period ending 2024-11-30, per its 10-K filed 2025-02-28.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 · last filed 2025-02-28
- CRYO-CELL INTERNATIONAL, INC. business combination, contingent consideration arrangements, change in amount of contingent consideration, liability for the quarter ending 2024-11-30 was -$1.03K.
- CRYO-CELL INTERNATIONAL, INC. business combination, contingent consideration arrangements, change in amount of contingent consideration, liability for the quarter ending 2024-08-31 was $12.70K, a 89.65% decline year-over-year.
- CRYO-CELL INTERNATIONAL, INC. business combination, contingent consideration arrangements, change in amount of contingent consideration, liability for the quarter ending 2024-05-31 was -$3.70K.
- CRYO-CELL INTERNATIONAL, INC. business combination, contingent consideration arrangements, change in amount of contingent consideration, liability for the quarter ending 2024-02-29 was -$5.18K.
- CRYO-CELL INTERNATIONAL, INC. business combination, contingent consideration arrangements, change in amount of contingent consideration, liability for fiscal 2024 was $2.79K.
- CRYO-CELL INTERNATIONAL, INC. business combination, contingent consideration arrangements, change in amount of contingent consideration, liability for fiscal 2023 was -$1.05M.
- CRYO-CELL INTERNATIONAL, INC. business combination, contingent consideration arrangements, change in amount of contingent consideration, liability for fiscal 2022 was -$1.05M.
- CRYO-CELL INTERNATIONAL, INC. business combination, contingent consideration arrangements, change in amount of contingent consideration, liability for fiscal 2021 was -$782.48K.
| Period end | Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability 3 month | Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability 3 month as first filed | Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability 6 month | Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability 9 month | Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability 12 month | Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability 12 month as first filed |
|---|---|---|---|---|---|---|
| 2024-11-30 | -$1.03K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $11.67K derived: sum of 2 quarters · filed 2025-02-28 | $7.97K derived: sum of 3 quarters · filed 2025-02-28 | $2.79K 10-K · filed 2025-02-28 | ||
| 2024-08-31 | $12.70K 10-Q · filed 2024-10-15 | $9.01K derived: sum of 2 quarters · filed 2024-10-15 | $3.83K 10-Q · filed 2024-10-15 | -$982.00K derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2024-05-31 | -$3.70K 10-Q · filed 2024-07-15 | -$8.87K 10-Q · filed 2024-07-15 | -$994.70K derived: sum of 3 quarters · filed 2025-02-28 | -$872.03K derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2024-02-29 | -$5.18K 10-Q · filed 2024-04-15 | -$991.00K derived: sum of 2 quarters · filed 2025-02-28 | -$868.33K derived: sum of 3 quarters · filed 2025-02-28 | -$891.45K derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-11-30 | -$985.82K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$863.15K derived: sum of 2 quarters · filed 2025-02-28 | -$886.28K derived: sum of 3 quarters · filed 2025-02-28 | -$1.05M 10-K · filed 2025-02-28 | ||
| 2023-08-31 | $122.67K 10-Q · filed 2024-10-15 | $99.55K derived: sum of 2 quarters · filed 2024-10-15 | -$65.15K 10-Q · filed 2024-10-15 | -$1.38M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-05-31 | -$23.12K 10-Q · filed 2024-07-15 | -$187.82K 10-Q · filed 2024-07-15 | -$1.50M derived: sum of 3 quarters · filed 2025-02-28 | -$1.09M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-02-28 | -$164.70K 10-Q · filed 2024-04-15 | -$1.48M derived: sum of 2 quarters · filed 2025-02-28 | -$1.06M derived: sum of 3 quarters · filed 2025-02-28 | -$1.10M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2022-11-30 | -$1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$898.44K derived: sum of 2 quarters · filed 2025-02-28 | -$934.54K derived: sum of 3 quarters · filed 2025-02-28 | -$1.05M 10-K · filed 2025-02-28 | $435.33K 10-K · filed 2023-02-28 | |
| 2022-08-31 | $412.31K 10-Q · filed 2023-10-12 | $376.20K derived: sum of 2 quarters · filed 2023-10-12 | $259.77K 10-Q · filed 2023-10-12 | $81.40K derived: sum of 4 quarters · filed 2023-10-12 | ||
| 2022-05-31 | -$36.10K 10-Q · filed 2023-07-14 | $36.10K 10-Q · filed 2022-07-11 | -$152.54K 10-Q · filed 2023-07-14 | -$330.91K derived: sum of 3 quarters · filed 2023-07-14 | -$655.81K derived: sum of 4 quarters · filed 2023-07-14 | |
| 2022-02-28 | -$116.43K 10-Q · filed 2023-04-21 | -$294.81K derived: sum of 2 quarters · filed 2023-04-21 | -$619.71K derived: sum of 3 quarters · filed 2023-04-21 | -$1.05M derived: sum of 4 quarters · filed 2023-04-21 | ||
| 2021-11-30 | -$178.37K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$503.28K derived: sum of 2 quarters · filed 2023-02-28 | -$934.88K derived: sum of 3 quarters · filed 2023-02-28 | -$782.48K 10-K · filed 2023-02-28 | ||
| 2021-08-31 | -$324.90K 10-Q · filed 2022-10-18 | -$756.50K derived: sum of 2 quarters · filed 2022-10-18 | -$604.11K 10-Q · filed 2022-10-18 | -$2.37M derived: sum of 4 quarters · filed 2022-10-18 | ||
| 2021-05-31 | -$431.60K 10-Q · filed 2022-07-11 | -$279.20K 10-Q · filed 2022-07-11 | -$2.05M derived: sum of 3 quarters · filed 2022-07-11 | -$2.20M derived: sum of 4 quarters · filed 2022-07-11 | ||
| 2021-02-28 | $152.39K 10-Q · filed 2022-04-13 | -$1.62M derived: sum of 2 quarters · filed 2022-04-13 | -$1.76M derived: sum of 3 quarters · filed 2022-04-13 | -$1.74M derived: sum of 4 quarters · filed 2022-04-13 | ||
| 2020-11-30 | -$1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | -$1.92M derived: sum of 2 quarters · filed 2022-02-22 | -$1.89M derived: sum of 3 quarters · filed 2022-02-22 | -$1.94M 10-K · filed 2022-02-22 | ||
| 2020-08-31 | -$145.75K 10-Q · filed 2021-10-15 | -$118.33K derived: sum of 2 quarters · filed 2021-10-15 | -$169.74K 10-Q · filed 2021-10-15 | -$276.38K derived: sum of 4 quarters · filed 2021-10-15 | ||
| 2020-05-31 | $27.42K 10-Q · filed 2021-07-15 | -$23.99K 10-Q · filed 2021-07-15 | -$130.63K derived: sum of 3 quarters · filed 2021-07-15 | -$95.98K derived: sum of 4 quarters · filed 2021-07-15 | ||
| 2020-02-29 | -$51.41K 10-Q · filed 2021-04-14 | -$158.05K derived: sum of 2 quarters · filed 2021-04-14 | -$123.40K derived: sum of 3 quarters · filed 2021-04-14 | -$1.16M derived: sum of 4 quarters · filed 2021-04-14 | ||
| 2019-11-30 | -$106.64K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$71.99K derived: sum of 2 quarters · filed 2021-03-01 | -$1.11M derived: sum of 3 quarters · filed 2021-03-01 | -$742.92K 10-K · filed 2021-03-01 | ||
| 2019-08-31 | $34.65K 10-Q · filed 2020-10-15 | -$1.00M derived: sum of 2 quarters · filed 2020-10-15 | -$636.28K 10-Q · filed 2020-10-15 | |||
| 2019-05-31 | -$1.04M 10-Q · filed 2020-07-10 | -$670.93K 10-Q · filed 2020-07-10 | ||||
| 2019-02-28 | $367.06K 10-Q · filed 2020-04-14 | |||||
| 2018-11-30 | -$415.28K 10-K · filed 2020-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |